Life expectancy at birth, 2021: 77.1 years
Maternal mortality ratio (per 100,000 live births), 2020: 3
Under-five mortality rate (per 1,000 live births), 2022: 3
Neonatal mortality rate (per 1,000 live births), 2022: 1
New HIV infections (per 1,000 uninfected population), 2022: 0.02
Tuberculosis incidence (per 100,000 population), 2022: 4.2
Probability of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, 2019: 14.3%
Suicide mortality rate (per 100,000 population), 2021: 13.3
Prevalence of overweight in children under 5, 2022: 6.1%
Age-standardized prevalence of hypertension among adults aged 30-79 years, 2019: 41.6%
Age-standardized prevalence of obesity among adults (18+ years), 2022: 26.0%
Source: World health statistics 2024: monitoring health for the SDGs, Sustainable Development Goals: Statistical Annex. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. Last accessed May 28, 2024.
Infant mortality, deaths per 1,000 live births, 2021: 2.2
Maternal mortality rate, deaths per 100,000 live births, 2020: 3.4
Congestive heart failure hospital admission in adults, age-sex standardized rate per 100,000 population, 2021: 357
Asthma and chronic obstructive pulmonary disease hospital admissions in adults, age-sex standardized rate per 100,000 population, 2021: 119
Source: OECD (2023), Health at a Glance 2023: OECD Indicators, OECD Publishing, Paris, doi.org/10.1787/7a7afb35-en.
“Mortality rates from preventable and treatable causes in Czechia are 25 % higher than the EU averages. Substantial room for improvement remains for public health interventions to reduce premature deaths from preventable causes and to provide more timely and effective healthcare to reduce mortality from treatable causes.”
Source: OECD/European Observatory on Health Systems and Policies (2023), Czechia: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.
“In 2021, Czechia distributed health expenditure evenly between inpatient and outpatient care, with each accounting for 30 % of the total (Figure 10).Pharmaceutical expenses represented 16 % of health spending2, while long-term care (LTC) accounted for 13 %. Smaller proportions were allocated to prevention (8 %) and administration and other spending (3 %).”
Source: OECD/European Observatory on Health Systems and Policies (2023), Czechia: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.
“Czechia’s spending on prevention in absolute per capita terms was only slightly below the EU average in 2021. Between 2020 and 2021, it increased almost 2.5 times, reflecting COVID-19-related spending on preventive measures such as vaccinations and testing.”
Source: OECD/European Observatory on Health Systems and Policies (2023), Czechia: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.
Czechia Health System Overview
Health System Rankings
Health System Outcomes
Coverage and Access
Costs for Consumers
Health System Expenditures
Health System Financing
Preventive Healthcare
World Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems and policies in the US and sixteen other OECD member nations.
Page last updated January 30, 2025 by Doug McVay, Editor.